Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 97

Results For "RSE"

1403 News Found

CHMP adopts positive opinion on Tabrecta for advanced non-small cell lung cancer
Biotech | April 23, 2022

CHMP adopts positive opinion on Tabrecta for advanced non-small cell lung cancer

With one of the most diverse lung cancer development programs, Novartis is focused on investments to advance the science, drive treatment and make an impact on patients


We continue to invest in R&D and new product development: Anish Bafna, CEO & MD, Healthium Medtech
interviews | April 22, 2022

We continue to invest in R&D and new product development: Anish Bafna, CEO & MD, Healthium Medtech

Healthium Medtech, a company focused on products used in surgical, post-surgical and chronic care has ramped up its play in the global healthcare industry. In an interview with Thomas C. Thottathil, Editor, Indian Pharma Post, Anish Bafna, CEO and MD, Healthium Medtech outlines his plans


First patients ‘filter free’ after laser-assisted Inferior Vena Cava (IVC) filter removal
Public Health | April 22, 2022

First patients ‘filter free’ after laser-assisted Inferior Vena Cava (IVC) filter removal

The first use of Philips' breakthrough CavaClear solution to help patients with embedded IVC filters, including an athlete suffering from a 16-year old penetrating filter


Phase 1/2 clinical trial of Covid-19-Influenza combination vaccine show positive results
Biotech | April 21, 2022

Phase 1/2 clinical trial of Covid-19-Influenza combination vaccine show positive results

Immune response confirmed in stand-alone influenza vaccine and combination vaccine with a potential path forward for both


Agilent joins the National Institute for Innovation in Manufacturing to advance biomanufacturing
News | April 21, 2022

Agilent joins the National Institute for Innovation in Manufacturing to advance biomanufacturing

Support for biologics manufacturability and Industry 4.0 initiatives


Alembic Pharmaceuticals receives USFDA tentative approval for heart failure drug
Drug Approval | April 20, 2022

Alembic Pharmaceuticals receives USFDA tentative approval for heart failure drug

Ivabradine Tablets, 5 mg and 7.5 mg have an estimated market size of US $ 102 million for twelve months ending December 2021 according to IQVIA


India Health Link join hands with U GRO Capital
Healthcare | April 20, 2022

India Health Link join hands with U GRO Capital

U GRO Capital is a listed MSME lending fintech platform


Leading inhalation APIs expert Inke to triple production capacity
Biotech | April 20, 2022

Leading inhalation APIs expert Inke to triple production capacity

To meet the growing global demand for respiratory active pharmaceutical ingredients (APIs), Inke is to invest €9 million into its production plant to reinforce focus on inhalation micronised APIs


Plasma-based green disinfectants can limit spread of infectious diseases like Covid-19
News | April 20, 2022

Plasma-based green disinfectants can limit spread of infectious diseases like Covid-19

Researchers have developed a plasma-based disinfectant generated with the help of cold atmospheric pressure plasma (CAP) which could act as a green decontaminant for Covid-19


Takeda announces approval of Nuvaxovid Covid-19 vaccine in Japan
Drug Approval | April 19, 2022

Takeda announces approval of Nuvaxovid Covid-19 vaccine in Japan

Approval for primary and booster immunization is based on efficacy and safety data from Japan and international clinical studies